These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1303668)

  • 21. [Detection of G-->T mutation at codon 12 of H-ras oncogenes in gastric cancers with polymerase chain reaction and oligodeoxynucleotide(PCR-ODN)].
    Liu XF
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):364-7. PubMed ID: 1299531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
    Fang Q; Li X; Li J; Liang S
    Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proto-oncogene point mutation of c-Ha-ras in bronchogenic carcinoma].
    Wang L; Li L; Zhu Y; Fang F; Zuo J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):281-5. PubMed ID: 8575050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ras gene mutations in human prostate cancer.
    Carter BS; Epstein JI; Isaacs WB
    Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.
    Tsuda T; Mochizuki M; Wakasa H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of point mutation at codon 12 of K-ras proto-oncogene in squamous cell carcinoma of the upper aerodigestive tract.
    Hirano T; Steele PE; Gluckman JL
    Ann Otol Rhinol Laryngol; 1991 Jul; 100(7):597-9. PubMed ID: 2064275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of point mutations of Ha-ras gene in basaliomas and spinaliomas usiang the polymerase chain reaction (PCR) technic].
    Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
    G Ital Dermatol Venereol; 1989 Oct; 124(10):429-34. PubMed ID: 2635687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras gene mutation and amplification in human nonmelanoma skin cancers.
    Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
    Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases.
    Warnakulasuriya KA; Chang SE; Johnson NW
    J Oral Pathol Med; 1992 May; 21(5):225-9. PubMed ID: 1403838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of ras oncogene activation in lung carcinomas in Hong Kong.
    Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW
    Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of C-Ha-ras gene amplification and mutation in laryngeal carcinoma.
    Liu S; Lin D; Hong B; Huang G
    Chin Med Sci J; 1995 Mar; 10(1):59-60. PubMed ID: 7780122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High incidence of H-ras oncogene mutations in squamous cell carcinoma of lip vermilion.
    Milasin J; Pujić N; Dedović N; Nikolić Z; Petrović V; Dimitrijević B
    J Oral Pathol Med; 1994 Aug; 23(7):298-301. PubMed ID: 7965884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin.
    van der Schroeff JG; Evers LM; Boot AJ; Bos JL
    J Invest Dermatol; 1990 Apr; 94(4):423-5. PubMed ID: 2179417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
    Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
    Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.